Company Profiles

driven by the PitchBook Platform

Swift Biosciences

Description

Developer of novel molecular biology technologies designed to better characterize and understand the genome. The company develops and enables technologies to examine disease-related genes, improve next generation sequencing sample preparation for Illumina and Ion Torrent platforms, and accelerate sample preparation for DNA sequencing enabling customers to have more usable data from next gen sequencing instruments.

2010

Founded

PRIVATE

Status

11-50

Employees

Later Stage VC

Latest Deal Type

$2.91M

Latest Deal Amount

$22.4M

Total Amount Raised

Description

Developer of novel molecular biology technologies designed to better characterize and understand the genome. The company develops and enables technologies to examine disease-related genes, improve next generation sequencing sample preparation for Illumina and Ion Torrent platforms, and accelerate sample preparation for DNA sequencing enabling customers to have more usable data from next gen sequencing instruments.

Website:

www.swiftbiosci.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Diagnostic Equipment

Other Industries

Discovery Tools (Healthcare)

Primary Office

58 Parkland Plaza Suite 100 Ann Arbor, MI 41803United States +1 (734) 330-2568
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Swift Biosciences's full profile, request a free trial.

Swift Biosciences Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Swift Biosciences Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Swift Biosciences Investors (4)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Fletcher Spaght VenturesVenture CapitalMinority000 0000000 0000
Mercury FundVenture CapitalMinority000 0000000 0000
Michigan Accelerator Fund 1Venture CapitalMinority000 0000000 0000
Renaissance Venture Capital FundFund of FundsMinority000 0000000 0000
Fletcher Spaght Ventures Venture Capital
Mercury Fund Venture Capital
Michigan Accelerator Fund 1 Venture Capital
Renaissance Venture Capital Fund Fund of Funds

Swift Biosciences Executive Team (5)

NameTitleBoard
Seat
Contact
Info
Timothy Harkins Ph.DChief Executive Officer, President & Board Member
Vladimir Makarov Ph.DCo-Founder, Chief Scientific Officer & Board Member
Matthew HymesMarketing Director
Haley FiskeChief Commercial Officer
Eric HalversonVice President, Finance
Timothy Harkins Ph.D Chief Executive Officer, President & Board Member
Vladimir Makarov Ph.D Co-Founder, Chief Scientific Officer & Board Member
Matthew Hymes Marketing Director
Haley Fiske Chief Commercial Officer
Eric Halverson Vice President, Finance

Swift Biosciences Board Members (7)

NameRepresentingRoleSinceContact
Info
Daniel Watkins Ph.DMercury FundCo-Founder & Partner000 0000
Jack Ball Jr.SelfBoard Member000 0000
Molly HoultFletcher Spaght VenturesDirector000 0000
Peter KleinhenzFletcher Spaght VenturesVenture Partner000 0000
Timothy Harkins Ph.DSwift BiosciencesChief Executive Officer, President & Board Member000 0000
Daniel Watkins Ph.D Co-Founder & Partner Mercury Fund
Jack Ball Jr. Board Member Self
Molly Hoult Director Fletcher Spaght Ventures
Peter Kleinhenz Venture Partner Fletcher Spaght Ventures
Timothy Harkins Ph.D Chief Executive Officer, President & Board Member Swift Biosciences
Request full access to PitchBook